Indian pharma company Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited has launched Lenalidomide Capsules, a generic of Revlimid, in the US market. The launch of Lenalidomide Capsules follows the final approvals for 5 mg, 10 mg, 15 mg and 25 mg strengths and tentative approvals for 2.5 mg and 20 mg strength from […]
Zydus Cadila said that its subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval from the US Food and Drug Administration (FDA) to commercialize Cariprazine Capsules in the strengths of 1.5 mg, 3 mg, and 4.5 mg, and 6 mg. The reference listed rug (RLD) of Cariprazine Capsules is VRAYLAR. Cariprazine, which is an atypical antipsychotic, […]
Zydus Cadila has secured final approval from the US Food and Drug Administration (FDA) for the commercialization of the cancer medication Decitabine for Injection in the strength of 50mg/vial Single-Dose Vial. Decitabine for Injection is a generic of Dacogen, which is approved for the treatment of myelodysplastic syndromes, some types of blood or bone marrow […]
Cadila Healthcare (Zydus Cadila) has bagged an order from the Indian government to deliver one crore doses of its ZyCoV-D Plasmid DNA Covid-19 vaccine. According to Zydus Cadila, the vaccines will be supplied at INR 265 per dose along with needle-free applicators priced at INR 93 per dose, excluding GST. The Indian pharma company said […]
Zydus Cadila (Cadila Healthcare) has dosed the first patient in the EVIDENCES-X phase 2b clinical trial of Saroglitazar Magnesium (Saroglitazar Mg) in non-alcoholic steatohepatitis (NASH). The multi-centre, randomized, double-blind, placebo-controlled trial will assess the safety and efficacy of Saroglitazar Magnesium in patients with NASH and fibrosis. The EVIDENCES-X clinical trial will randomly group 240 patients […]
Zydus Cadila has secured tentative approval from the US Food and Drug Administration (FDA) for marketing Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%. A generic of Galderma’s Epiduo Forte, Adapalene and Benzoyl Peroxide Gel 0.3%/2.5% is intended for the treatment of acne. The combination of adapalene and benzoyl peroxide works by destroying the bacteria that cause […]
Zydus Cadila said that its subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) to market Apremilast Tablets, a drug for psoriasis. The approval is for the strengths of 10 mg, 20 mg, and 30 mg. Apremilast Tablets is a generic of Otezla Tablets, which is indicated for […]
Zydus Cadila has secured final approval from the US Food and Drug Administration (FDA) to market Vortioxetine Tablets in the strengths of 5mg, 10mg, 20mg for the treatment of depression. The reference listed drug (RLD) of Vortioxetine Tablets is Trintellix Tablets in the US. Vortioxetine is a selective serotonin reuptake inhibitor (SSRI) and serotonin receptor […]
Zydus Cadila said that its subsidiary has been granted tentative approval from the US Food and Drug Administration (FDA) for its new drug application (NDA) for Sitagliptin base 25, 50, and 100 mg tablets. The Indian pharma company said that Sitagliptin base has the active moiety Sitagliptin in a different form than the one used […]
Zydus Cadila said that the US Food and Drug Administration (FDA) has granted it tentative approval for Lenalidomide Capsules, a generic version of Celgene Corporation’s Revlimid (Lenalidomide). The FDA tentative approval is for Lenalidomide Capsules in the strengths of 2.5 mg, 5 mg,10 mg, 15 mg, 20 mg, and 25 mg. Lenalidomide is used for […]